logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Mid Cap

Eris Lifesciences Share Price

Eris Lifesciences Ltd.

₹1,301.90

4.70(0.36%)

Invest in ERIS with up to 2.86x margin.

Trade with MTF
1st Apr 2026 | 1:02 PM
NSE : ERIS
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Eris Lifesciences Performance

Price Movement

₹1301.90

₹1281.70

₹1350.60

↘ Today's Low↗ Today's High

1 Year Performance

₹1301.90

₹1097.20

₹1910.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,350.60
Low₹1,281.70
Open at₹1,312.90
Prev Close₹1,297.20
Volumes43.96 K
Avg Price₹1,303.31
Lower Circuit₹1,037.80
Upper Circuit₹1,556.60

Historical Performance

3M High₹1,563.00
3M Low₹1,236.00
1 Yr High₹1,910.00
1 Yr Low₹1,097.20
3 Yr High₹1,910.00
3 Yr Low₹566.30
5 Yr High₹1,910.00
5 Yr Low₹551.30

Eris Lifesciences Fundamentals

Market Cap
High in industry
17,971.80 Cr.
PE Ratio (TTM)
High in industry
41.60
Dividend Yield
0
Net Profit TTM
31.1% incr over last year
431.74
Net Profit Growth
31.1% incr over last year
431.74
PEG Ratio
High in industry
1.30
ROE
19% decr over last year
12.32
Operating Revenue TTM
3,078.16
Operating Revenue Growth
12.5% incr over last year
Book Value
High in industry
5.60
MFI
MFI is mid-range
43.05
RSI
RSI is mid-range
42.60
EPS (TTM)
25.85
Debt to Equity
0.85
Face Value
1
Operating Profit Margin Qtr.
34.93
Operating Profit Qtr.
281.61
Net Profit Qtr.
99.72
Operating Revenue Qtr.
807.45
PB Ratio
5.60

Eris Lifesciences Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue315.29650.50578.64404.77399.73
Operating Expense237.94353.62362.32283.80300.16
Operating Profit77.35296.88216.32120.9799.57
Depreciation38.6639.3037.6043.3846.68
Interest45.2046.5045.1453.1654.65
Tax0.8085.1056.2710.714.25
Net Profit3.09149.5799.9930.471.78

ERIS Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹1,574 - ₹0

Target Price

₹1,810

Stop Loss

-

Target Date

13 Nov 26

Potential Returns

14.99 %

View Call ↗

Eris Lifesciences Technicals

Eris Lifesciences Ltd. EMA & SMA

₹1301.90

-39.00 (-2.91%)

↗ Bullish Moving Average

0

↘ Bearish Moving Average

16

Day EMA5 ₹1309.4
Day EMA10 ₹1310.6
Day EMA12 ₹1312.8
Day EMA20 ₹1324.8
Day EMA26 ₹1334.8
Day EMA50 ₹1375.4
Day EMA100 ₹1441.3
Day EMA200 ₹1480.7

Eris Lifesciences Support and Resistance

Resistance

First Resistance₹1331.90
Second Resistance₹1366.60
Third Resistance₹1394.20

Support

First Support₹1269.60
Second Support₹1242.00
Third Support₹1207.30

Technical Indicators

Day RSI42.60
Day MFI43.05
Day ADX29.39
Day Commodity Channel Index-51.80
William-51.20
Day MACD-21.99
Day MACD Signal Line-25.47
Day ATR45.58
Day ROC125-20.23
Day ROC21-6.01

Eris Lifesciences Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter54.954.954.854.854.854.8
FII88.48.48.47.26.8
DII18.61818.118.219.420.4
Public18.518.718.618.618.618

Eris Lifesciences Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day2.94 L3.58 L82.18%
Week1.62 L2.03 L79.53%
1 Month77.98 K1.06 L73.66%
6 Month55.65 K1.2 L46.28%

Eris Lifesciences SWOT Analysis

Strengths12
Weakness13
Opportunity7
Threats0

Benjamin Graham Value Screen

Consistent high performing stocks over Five Years

Mid-range Performer (DVM)

Rising Net Cash Flow and Cash from Operating activity

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Volume Shockers

Eris Lifesciences Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
13 Feb, 20257.35INTERIM13 Feb, 2025Equity Share
11 Aug, 20227.35INTERIM16 Aug, 2022Equity Share
05 Aug, 20216.01INTERIM06 Aug, 2021Equity Share
13 Aug, 20205.5INTERIM14 Aug, 2020Equity Share
19 Mar, 20202.87INTERIM20 Mar, 2020Equity Share

Eris Lifesciences Stock Comparison

Financials
Corona Remedies Ltd.
Sudeep Pharma Ltd.
Rubicon Research Ltd.
Sanofi India Ltd.
Procter & Gamble Health Ltd.
Jeena Sikho Lifecare Ltd.
Price (₹)₹1,560.70₹607.80₹781.35₹3,257.20₹4,826.70₹584.15
% Change0.30%2.57%1.11%1.48%0.58%8.24%
Revenue TTM (₹ Cr)--₹1,598.19₹1,837.40₹1,348.51₹724.81
Net Profit TTM (₹ Cr)--₹206.20₹326.70₹293.49₹204.17
PE TTM--61.7022.6027.1032.90
1 Year Return46.52-0.0859.34-43.94-6.7623.63
ROCE30.2434.7834.7652.72-35.59

Similar Stocks

ONESOURCE

OneSource Specialty Pharma Ltd.

₹ 1469.30

-0.27%

SANOFICONR

Sanofi Consumer Healthcare India Ltd.

₹ 4508.00

+4.88%

AKUMS

Akums Drugs & Pharmaceuticals Ltd.

₹ 496.15

+6.45%

BLUEJET

Blue Jet Healthcare Ltd

₹ 353.65

+8.07%

CONCORDBIO

Concord Biotech Ltd.

₹ 1023.50

+0.50%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 635.95

+7.43%

PPLPHARMA

Piramal Pharma Ltd.

₹ 142.47

+4.34%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2331.00

-8.90%

ALIVUS

Alivus Life Sciences Ltd.

₹ 999.00

+2.70%

COHANCE

Cohance Lifesciences Ltd.

₹ 310.65

+3.05%

SYNGENE

Syngene International Ltd.

₹ 400.05

+2.60%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 673.60

+1.56%

STAR

Strides Pharma Science Ltd.

₹ 970.40

+3.48%

GRANULES

Granules India Ltd.

₹ 632.45

+1.94%

WOCKPHARMA

Wockhardt Ltd.

₹ 1281.90

+9.03%

FDC

FDC Ltd.

₹ 332.40

+3.52%

SHILPAMED

Shilpa Medicare Ltd.

₹ 377.10

+8.08%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 820.00

+0.43%

NATCOPHARM

Natco Pharma Ltd.

₹ 1002.30

+2.88%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1589.50

+5.63%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 12718.00

+5.75%

MARKSANS

Marksans Pharma Ltd.

₹ 170.16

+8.46%

FAQ's on ERIS

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy